TScan Therapeutics (TCRX) Share-based Compensation (2020 - 2026)
TScan Therapeutics' Share-based Compensation came in at $2.36 million for Q2 2026, down 28.0% from $3.27 million a year earlier and down 4.4% from the prior quarter.
Powered by 
Analysis
TScan Therapeutics (TCRX) Share-based Compensation (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, TScan Therapeutics reported Share-based Compensation of $9.84 million, down 17.5% year-over-year; for FY2025, it was $11.71 million, up 22.6% from FY2024.
- Share-based Compensation has increased in each of the last five years, with a five-year compound annual growth rate of 86.8% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $9.55 million in FY2024 (+83.4%), $5.21 million in FY2023 (+14.4%), $4.55 million in FY2022 (+80.9%) and $2.52 million in FY2021 (+388.5%).
- The five-year range for quarterly Share-based Compensation is $784,000 (Q4 2021) to $3.41 million (Q1 2025).
- Year-over-year, Share-based Compensation has declined for three consecutive quarters, with growth averaging 27.4% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q3 2021 (growth of 586.0%), and the weakest in Q2 2026 (a decline of 28.0%).
- Business Quant data shows TCRX's Share-based Compensation at $2.47 million (Q1 2026), $2.01 million (Q4 2025) and $3.01 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | TScan Therapeutics | 40.28 Mn | 40.28 Mn | - | 2.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.36 Mn |
| Mar 31, 2026 | 2.47 Mn |
| Dec 31, 2025 | 2.01 Mn |
| Sep 30, 2025 | 3.01 Mn |
| Jun 30, 2025 | 3.27 Mn |
| Mar 31, 2025 | 3.41 Mn |
| Dec 31, 2024 | 2.71 Mn |
| Sep 30, 2024 | 2.52 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Mar 31, 2024 | 1.98 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Sep 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 1.15 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Sep 30, 2022 | 1.25 Mn |
| Jun 30, 2022 | 1.02 Mn |
| Mar 31, 2022 | 984,000.00 |
| Dec 31, 2021 | 784,000.00 |
| Sep 30, 2021 | 885,000.00 |
API Access
TScan Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();